Connection
David Becton to Bleomycin
This is a "connection" page, showing publications David Becton has written about Bleomycin.
|
|
Connection Strength |
|
|
|
|
|
0.153 |
|
|
|
-
Mack JM, Richter GT, Becton D, Salem O, Hill SEM, Crary SE. Short-term side effects and patient-reported outcomes of bleomycin sclerotherapy in vascular malformations. Pediatr Blood Cancer. 2018 06; 65(6):e27008.
Score: 0.153